Table 2.
Parameter | Quercetin (n=40) | Placebo (n=31) | Pb | Pc | ||||
---|---|---|---|---|---|---|---|---|
Before | After | P1 | Before | After | Pa | |||
AST (IU/L) | 31.00 (42.00) | 24.00 (31.75) | <0.001 | 47.00 (36.25) | 39.00 (23.00) | <0.001 | 0.293 | 0.163 |
ALT (IU/L) | 25.00 (57.25) | 17.00 (28.50) | <0.001 | 38.00 (28.50) | 31.00 (33.50) | 0.178 | 0.195 | 0.002 |
ALP (IU/L) | 179.00 (83.25) | 172.00 (82.00) | 0.197 | 219.50 (107.75) | 227.50 (133.75) | 0.885 | 0.043 | 0.107 |
TAC (mmol/L) | 2.89 (0.74) | 3.44 (0.97) | <0.001 | 2.81 (0.79) | 2.86 (0.92) | 0.593 | 0.010 | 0.142 |
GPx (U/L) | 660.00 (763.95) | 487.90 (732.95) | 0.971 | 564.00 (882.73) | 432.90 (738.58) | 0.277 | 0.169 | 0.093 |
SOD (U/L) | 464.25 (596.75) | 631.95 (348.38) | 0.438 | 441.90 (563.28) | 466.90 (485.03) | 0.739 | 0.158 | 0.111 |
MDA (µmol/L)* | 18.59±6.21 | 17.31±7.19 | 0.401 | 16.87±5.23 | 16.37±5.33 | 0.549 | 0.497 | 0.995 |
*Mean±SD, aWithin-group comparison; bBetween-group comparison after the trial (nonadjusted); cBetween-group comparison (adjusted). MDA=Malondialdehyde; TAC=Total antioxidant capacity; SOD=Superoxide dismutase; GPx=Glutathione peroxidase; AST=Aspartate aminotransferase; ALT=Alanine aminotransferase; ALP=Alkaline phosphatase; SD=Standard deviation